[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356687-105":59,"doc-detail-356687-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","prognostic-significance-of-myopenia-myosteatosis-and-frailty-in-older-patients-with-prostate-cancer-undergoing-definitive-radiotherapy","Prognostic Significance of Myopenia, Myosteatosis, and Frailty in Older Patients With Prostate Cancer Undergoing Definitive Radiotherapy","","Study evaluates whether myopenia, myosteatosis, and frailty independently predict survival in older men with prostate cancer treated with definitive radiotherapy. A retrospective cohort of 124 patients aged 65+ (2014–2023) measured myopenia via psoas muscle index (PMI) and myosteatosis via Hounsfield unit average calculation (HUAC), while frailty was assessed using modified frailty index-11 (mFI-11). ROC-defined cutoffs were applied, and Cox regression tested progression-free survival and overall survival. Only PMI-defined myopenia remained independently associated with both outcomes, suggesting opportunistic prognostic stratification from routine planning CT, pending external prospective confirmation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/prognostic-significance-of-myopenia-myosteatosis-and-frailty-in-older-patients-with-prostate-cancer-undergoing-definitive-radiotherapy/356687/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/prognostic-significance-of-myopenia-myosteatosis-and-frailty-in-older-patients-with-prostate-cancer-undergoing-definitive-radiotherapy/356687.png","ImageObject",300,407,{"name":92,"@type":93},"Quinn Holloway","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-20","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the study’s main objective?","Question",{"text":112,"@type":113},"To evaluate whether myopenia, myosteatosis, and frailty have independent associations with survival outcomes in older patients with prostate cancer undergoing definitive radiotherapy.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were myopenia and myosteatosis measured?",{"text":117,"@type":113},"Myopenia was quantified using the psoas muscle index (PMI), and myosteatosis was quantified using the Hounsfield unit average calculation (HUAC).",{"name":119,"@type":110,"acceptedAnswer":120},"Which marker showed independent prognostic value?",{"text":121,"@type":113},"Only PMI-defined myopenia remained independently associated with both progression-free survival and overall survival after adjustment in parsimonious multivariable Cox models.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},356687,1790779617,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336474466712,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Research Article  \n\n| Prognostic Significance of Myopenia, Myosteatosis, and Frailty in Older Patients With Prostate Cancer Undergoing Definitive Radiotherapy | Cancer Control Volume 33: 1–14 © The Author(s) 2026 Article reuse guidelines:\u003Cbr>[sagepub.com/journals-permissions](sagepub.com/journals-permissions)\u003Cbr>[DOI: 10.1177/10732748261446040](DOI: 10.1177/10732748261446040)\u003Cbr>[journals.sagepub.com/home/ccx](journals.sagepub.com/home/ccx)\u003Cbr>\u003Cbr>|\n| --- | --- |\n| Rahmi Atıl Aksoy1 , Timur Koca2 , Durmuş Ali Çetmi2 , Mehmet Kızılkaya2 , and Aylin Fidan Korcum2 \u003Cbr>Abstract\u003Cbr>Introduction: This study aimed to evaluate the independent associations of myopenia, myosteatosis, and frailty with survival outcomes in older patients with prostate cancer undergoing definitive radiotherapy. Methods: A total of 124 patients aged ≥65 years who received definitive radiotherapy for localized or locally advanced prostate cancer between 2014 and 2023 were retrospectively analyzed. Myopenia and myosteatosis were quantified using the psoas muscle index (PMI) and Hounsfield unit average calculation (HUAC), respectively. Comorbidity-based frailty was assessed using the modified frailty index-11 (mFI-11) . The cut-off points for the PMI and HUAC were determined using receiver operating characteristic (ROC) curve analysis. Univariate and parsimonious multivariable Cox regression analyses were used to examine the prognostic value of these markers for progression-free survival (PFS) and overall survival (OS) . Results: The median age of the patients was 72 years (range: 65–87). According to the mFI-11, 47.6% of the patients were classified as frail. The cut-off values for PMI and HUAC were 2.0 cm2/m2 and 37.7 HU, respectively. In univariate analysis, only PMI was significantly associated with both PFS (HR: 2.23, p = 0.02) and OS (HR: 2.45, p = 0.03) . When entered separately into parsimonious multivariable Cox models adjusted for age and NCCN risk group, PMI remained an independent prognostic factor for both PFS (HR: 2.36, p = 0.01) and OS (HR: 2.40, p = 0.04), whereas mFI-11 and HUAC were not significantly associated with either endpoint. Conclusion: Among the evaluated body composition and frailty-related markers, only PMI-defined myopenia remained independently associated with both PFS and OS in older patients receiving definitive radiotherapy for localized or locally advanced prostate cancer. As PMI can be obtained opportunistically from routine planning CT, it may have value for prognostic stratification, although confirmation in external prospective datasets is required.\u003Cbr>Plain Language Summary\u003Cbr>Prostate cancer is common in older men, who often have other health problems and may be physically weaker. Doctors need simple tools to estimate how long these patients are likely to live and how well they might do after radiotherapy. In this study, we examined 124 men aged 65 years or older who received radiotherapy for prostate cancer that had not spread to distant organs. Before treatment, all patients had routine planning CT scans. From these scans, we measured the size of a large muscle in the lower back (the psoas muscle) and calculated a value called the psoas muscle index, which reflects overall muscle mass. We also assessed muscle quality and a standard frailty score based on other illnesses and general condition. We |  |\n| 1Department of Radiation Oncology, Izmir City Hospital, Izmir, Turkey\u003Cbr>2Department of Radiation Oncology, Akdeniz University School of Medicine, Antalya, Turkey\u003Cbr>Corresponding author:\u003Cbr>Timur Koca, Department of Radiation Oncology, Akdeniz University School of Medicine, Pınarbaşı Neighborhood, Dumlupınar Boulevard, Akdeniz University Hospital, 07070, Antalya, Turkey.\u003Cbr>Email: [timurkoca3@gmail.com](timurkoca3@gmail.com) |  |\n\nCreative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons  \nAttribution-NonCommercial 4.0 License ([https://creativecommons.org/licenses/by","cbCaibGf2dF1A2dx","https://ap.wps.com/l/cbCaibGf2dF1A2dx","pdf",4204523,14,"English","# Abstract\n# Introduction\n# Methods\n# Results\n# Conclusion\n# Plain Language Summary\n# Keywords","[{\"question\":\"What was the study’s main objective?\",\"answer\":\"To evaluate whether myopenia, myosteatosis, and frailty have independent associations with survival outcomes in older patients with prostate cancer undergoing definitive radiotherapy.\"},{\"question\":\"How were myopenia and myosteatosis measured?\",\"answer\":\"Myopenia was quantified using the psoas muscle index (PMI), and myosteatosis was quantified using the Hounsfield unit average calculation (HUAC).\"},{\"question\":\"Which marker showed independent prognostic value?\",\"answer\":\"Only PMI-defined myopenia remained independently associated with both progression-free survival and overall survival after adjustment in parsimonious multivariable Cox models.\"}]","Prognostic Significance of Myopenia, Myosteatosis, and Frailty in Older Patients With Prostate Cancer Undergoing Definitive Radiotherapy | PDF",1790126798,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/df22d6d870f2304a6a58fe1e5d9d0460.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8953d8be4eab953974dac0b5d75b47b8.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4adcd46c75cc954223bc66e8b4ca24b5.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2687cec1978d7adc2ed740bfbd3c688e.webp",980,1306]